Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7170	Lucidin (NSC 30546)	Lucidin (NSC 30546) is a natural component of Rubia tinctorum L. lucidin is mutagenic in bacteria and mammalian cells.
DC22596	LUF6000	LUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor, enhance Emax but without affecting agonist potency.
DC23647	LUF7346 Featured	LUF7346 is a novel hERG allosteric modulator that slows IKr deactivation and positively shifting IKr inactivation.
DC8611	Luliconazole Featured	Luliconazole(NND 502) is an azole antifungal indicated for the topical treatment of interdigital tinea pedis.
DC22906	Lumateperone Featured	Lumateperone (ITI-007) is a potent 5-HT2A antagonist (Ki=0.54 nM), postsynaptic D2 antagonist(Ki=32 nM), and SERT blocker (Ki= 61 nM).
DC20271	LUT014 Featured	LUT014 is a novel BRAF agonist.
DC12120	Luteolin-7-rutinoside	Luteolin-7-rutinoside has both anti-arthritic and antifungal activities, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection.
DC23133	LX-1031	LX-1031 is a potent, orally active tryptophan 5-hydroxylase (TPH) inhibitor with potency of 10-100 nM, reduces 5-HT synthesis peripherally.
DC21251	LX-2931	LX-2931 (LX2931) is a potent, selective and orally bioavailable S1P lyase (S1PL) inhibitor.
DC23136	LX7101	LX7101 is a potent, dual LIMK and ROCK inhibitor with IC50 of 4.3/32//69/32/ nM for LIMK2/LIMK1/ROCK1/ROCK2, respectively.
DC26012	LXS-196 Featured	LXS196 is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. It can be used for the treatment of uveal melanoma.
DC21256	LY 2318912	LY 2318912 is a potent, competitive, small molecule inhibitor of anandamide uptake with IC50 of 7.27 nM, shows high affinity against anandamide transporter binding site with Kd o f7.62 nM.
DC8602	LY311727 Featured	LY 311727 is a specific group II sPLA2 (phospholipase A2 (PLA2)) inhibitor which has been reported to attenuate VEGF-mediated platelet-activating factor (PAF) synthesis in HUVEC and BAEC cells.
DC23633	LY 392098	LY 392098 is a selective, potent and centrally active positive allosteric modulator of AMPAR.
DC7944	LY2090314 Featured	LY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50s of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β respectively.
DC12130	LY223982	LY223982 is a potent and specific inhibitor of leukotriene B4 receptor, with an IC50 of 13.2 nM against [3H]LTB4 binding to LTB4 receptor.
DC9304	LY2334737 Featured	LY2334737 is an orally available prodrug of gemcitabine which is a nucleoside analog used as chemotherapy.
DC9975	Ly 2365109 Hydrochloride;n-[2-[4-(1,3-benzodioxol-5-yl)-2-(1,1-dimethylethyl)phenoxy]ethyl]-n-methylglycinehydrochloride Featured	LY2365109 is a potent and selective GlyT1 inhibitors with IC50 value of 15.8 nM.
DC23720	LY2452473 Featured	LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM).
DC24072	LY-2584702 free base Featured	LY2584702 is a potent, selective, ATP-competitive inhibitor of P70 S6 kinase-1 (p70S6K1) with IC50 of 4 nM.
DC24073	LY-2584702 hydrochloride Featured	LY2584702 is a potent, selective, ATP-competitive inhibitor of P70S6 kinase-1 (p70S6K1) with IC50 of 4 nM.
DC7458	LY2608204 Featured	LY2608204 is a activator of glucokinase (GK) with EC50 of 42 nM.
DC22140	LY2623091	LY2623091 (LY-2623091) is an orally administered mineralocorticoid receptor antagonist for the treatment of essential hypertension and chronic kidney disease..
DC23444	LY2624803	LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia..
DC23510	LY2794193 Featured	LY2794193 is a highly potent and selective mGlu3 receptor agonist with Ki of 0.93 nM and EC50 of 47 nM, >100-fold selectivity over mGlu2 receptor..
DC10815	LY2795050 Featured	LY2795050 is a novel selective κ-opioid Receptor (KOR) antagonist (IC50=0.72 nM) and has the potential as a PET tracer to image KOR in vivo.
DC7035	Merestinib(LY2801653 dihydrochloride) Featured	LY2801653 2HCl is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase(Ki= 2 nM).
DC8586	LY2801653 Featured	LY2801653 is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase(Ki= 2 nM).
DC22595	LY2857785	LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
DC22312	LY2940094 Featured	LY2940094 is a potent and selective nociceptin receptor antagonist which inhibits excessive feeding behavior in rodents.

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.